Kate Thomson

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Combination Therapy

Diabetic Retinopathy

Top Venues

Scientific reports

Clinical and translational science

British journal of pharmacology

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Kate Thomson, Cindy Karouta, Faran Sabeti, Nicola Anstice, Myra Leung, Tina Jong, Ted Maddess, Ian G Morgan, Jeremy Game, Regan Ashby
The safety and tolerability of levodopa eye drops for the treatment of ocular disorders: A randomized first-in-human study. Clinical and translational science 15 (11) (2022)
Kate Thomson, Jeremy Game, Cindy Karouta, Ian G Morgan, Regan Ashby
Correlation between small-scale methylation changes and gene expression during the development of myopia. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (1) (2022)
Kate Thomson, Tamsin Kelly, Cindy Karouta, Ian G Morgan, Regan Ashby
Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release. British journal of pharmacology 178 (22) (2021)
Kate Thomson, Cindy Karouta, Ian Morgan, Tamsin Kelly, Regan Ashby
Effectiveness and safety of topical levodopa in a chick model of myopia. Scientific reports 9 (1) (2019)